|
ABCB10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
6.92680357516906E-11 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62547753035369E-12 |
| Stage1-vs-Stage2 |
4.417400E-01 |
| Stage1-vs-Stage3 |
4.888000E-01 |
| Stage1-vs-Stage4 |
1.775770E-01 |
| Stage2-vs-Stage3 |
2.975000E-01 |
| Stage2-vs-Stage4 |
1.523600E-01 |
| Stage3-vs-Stage4 |
5.393600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
9.46330014350849E-10 |
| Normal-vs-Asian |
1.6610046671417E-12 |
| Caucasian-vs-AfricanAmerican |
7.141800E-01 |
| Caucasian-vs-Asian |
9.858400E-01 |
| AfricanAmerican-vs-Asian |
7.292600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
8.762000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
1.62647673107585E-12 |
| Normal-vs-Age(81-100Yrs) |
1.70736999999255E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.342000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.772000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.357400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.693610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.700400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.253000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.515900E-02 |
| Classical-VS-Follicular |
8.777200E-01 |
| Classical-VS-Other |
4.902400E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
8.130500E-02 |
| Tall-VS-Other |
9.120400E-01 |
| Tall-VS-Normal |
1.62481139653892E-12 |
| Follicular-VS-Other |
5.058600E-01 |
| Follicular-VS-Normal |
1.64612767861172E-12 |
| Other-VS-Normal |
1.55367999999934E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
7.077500E-02 |
|
|
